SP

Steven Paul

North America, Massachusetts, United States, Cambridge

Description

Steven Paul is our Interim President of R&D, a member of the Board of Directors and a Venture Partner at Third Rock Ventures. Steven Paul ha...

Investor Profile

Steven Paul has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Health Care, Therapeutics.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Steven Paul frequently co-invest with?

PureTech Health
North America, Massachusetts, United States, Boston
Co-Investments: 1
Wellcome Trust
Europe, England, United Kingdom, London
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Steven Paul?

Karuna Therapeutics

Boston, Massachusetts, United States

Karuna Therapeutics is a biopharmaceutical company that develops and delivers medicines for psychiatric and neurological conditions.

BiopharmaHealth CareTherapeutics
Series AAug 2, 2018
Amount Raised: $42,000,000